Method for treating active bleeding by sequentially applying a biocompatible hemostatic composition and a sealant composition
US11998653B2 · kind B2 · utility
0Cited by
33References
14Claims
0Family size
Inventors
Key dates
| Filing date | Jan 10, 2019 |
| Grant date | Jun 4, 2024 |
| Priority date | — |
| Expiry date | Jun 19, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/04
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present specification describes a biocompatible hemostatic composition and a biocompatible tissue sealant, which when used in combination provides a safe and effective method of achieving hemostasis. The biocompatible composition and sealant may be applied either on a surface of the patient's body, or inside the body cavity. The combination may be used to control bleeding from external wounds and internal injuries, as well as to minimize bleeding during surgical procedures.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.